Cibc World Market Inc. Red Hill Biopharma Ltd. Transaction History

Cibc World Market Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.14 - $695.9 $7,630 - $37.9 Million	-54,500 Reduced 83.11%	11,075 $2,000
Q4 2021 Feb 14, 2022	BUY	$2.31 - $5.85 $125,895 - $318,825	54,500 Added 492.1%	65,575 $169,000
Q2 2021 Aug 12, 2021	BUY	$5.98 - $7.51 $66,228 - $83,173	11,075 New	11,075 $76,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $487M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.